Familial hypercholesterolemia (FH) 
Introduction
Familial hypercholesterolemia (FH)' is an autosomal dominant disorder caused by mutations in the gene coding for the LDL receptor (1) . The LDL receptor is a transmembrane glycoprotein that mediates the transport of LDL into cells and is pivotal in cholesterol homeostasis (2) . Individuals who are heterozygous for a mutation in the LDL homozygotes) or different (compound heterozygotes). These individuals have dramatically elevated plasma LDL levels and develop ischemic heart disease in childhood (1) . After the LDL receptor gene was cloned (3), numerous mutant alleles from FH homozygotes were characterized at the molecular level. A vast array of mutations, including insertions, deletions, nonsense, and missense mutations have been described (4) and rarely has the same mutation been found in two unrelated individuals. The diversity of mutations responsible for FH has complicated the development of molecular assays to detect mutations at this locus for the purpose of prenatal diagnosis.
Despite the general diversity of mutations, in three populations specific mutant alleles have been shown to be common. A nonsense mutation in the LDL receptor gene has been found exclusively in FH homozygotes of Christian Lebanese descent (5) . In a survey of French Canadian FH heterozygotes from the Montreal region, 60% were shown to have the same large deletion in the 5' region of their LDL receptor gene (6) . Finally, a deletion in the 3' end of the LDL receptor gene is common in the Finnish population (7) . The distinguishing features of these three populations are that they all originate from a small number of founders and have remained genetically isolated. The frequencies of FH in these populations are strikingly higher than in the general world population, where the frequency is 0.2% (1) .
Another population with a high frequency of FH is the Afrikaner of South Africa, where the frequency of FH has been estimated to be about five times that of other populations (8) (9) (10) . The Afrikaners are descended from a small number of original settlers whose offspring remained genetically isolated while undergoing a rapid numerical expansion (1 1-13). Biosynthetic studies of the LDL receptor protein in cultured fibroblasts derived from skin biopsies of Afrikaner FH homozygotes have demonstrated at least two different mutant alleles (14, 15). The normal LDL receptor protein is composed of 839 amino acids. In the endoplasmic reticulum (ER), N-linked and nascent 0-linked sugar chains are added to the amino acid backbone to produce a precursor protein with an apparent molecular weight of 120,000. Within -30 min, the precursor is transported from the ER to the Golgi complex and the apparent molecular weight increases by 40,000 due to maturation of the sugar moieties (2) . One of the Afrikaner mutations results in the production of a normal-sized LDL receptor precursor whose processing to the mature 160-kD form is retarded. The LDL receptor protein that reaches the cell surface is defective in LDL binding. The other mutant allele also produces an LDL receptor precursor which is processed slightly more slowly than usual to its mature form and is then rapidly degraded (14, 15) .
In this study, we used 10 restriction fragment length polymorphisms (RFLPs) associated with the LDL receptor gene to (19) (specific activity = 3,000 Ci/mmol) and one was unlabeled. After amplification, the entire DNA sample was size-fractionated on a 6% polyacrylamide gel in buffer A (50 mM Tris-borate, 90 mM boric acid, 2 mM EDTA at pH 8.3) at 200 V and 50 mA. The band corresponding to the amplified exon sequences was excised from the gel, crushed and soaked overnight in I ml of buffer (0.5 M ammonium acetate, 10 mM magnesium acetate, and 1 mM EDTA), purified, and subjected to DNA sequence analysis using the technique of Maxam and Gilbert (20) .
Detection ofmutant alleles by restriction analysis. Genomic DNA sequences flanking and including each mutation were selectively amplified using one labeled and one unlabeled oligonucleotide. An aliquot ofthe amplified product (20-50 ng) was purified and subjected to restriction enzyme analysis. The DNA was digested twice with a restriction endonuclease that was expected to detect the mutant allele, electrophoresed on a nondenaturing 6% polyacylamide gel in buffer A, and subjected to autoradiography on Kodak XAR-5 film for 1 h at 24°C.
Mutagenesis and transfection ofmammalian cells. DNA fragments from the expression plasmid pLDLR4 were subcloned into the bacteriophage M 13, and oligonucleotide-directed mutagenesis was performed as previously described (21) . The relevant mutation was confirmed by sequencing and a fragment containing the mutation was subcloned into pLDLR-2, a plasmid containing a cDNA encoding the human LDL receptor under the control of the Simian Virus (SV)-40 early promoter (21 The high frequency of two LDL receptor haplotypes in the Afrikaner homozygotes suggested that each of the two common haplotypes might be associated with a different mutation. Therefore, an individual homozygous for haplotype 3 (FH-la) and an individual homozygous for haplotype 15 (FH-3a) were selected for further analysis. Genomic DNA from each ofthese two patients was subjected to gene amplification by polymerase chain reaction using pairs of oligonucleotides homologous to intron sequences flanking each exon of the LDL receptor gene. In each amplification reaction one end-labeled and one unlabeled oligonucleotide were used. The amplification products were size-fractionated on a polyacrylamide gel and the amplified DNA fragments were excised and purified. Each DNA fragment, containing a single exon, was subjected to sequence analysis using the Maxam and Gilbert technique (20) . Both strands ofexons [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] as well as the coding region of exon 18 of the LDL receptor gene were sequenced. The sequence of each LDL receptor gene was compared with the normal sequence (24) and only one basepair difference was found in each FH homozygote (Fig. 1) . Fig. 1 found and the resultant amino acid change is an aspartic to a glutamic acid. Fig. 1 B shows the sequence of the noncoding strand of exon 9 from a normal individual and FH-3a. The sequences are identical, excluding the codon for amino acid 408. In the third position of this codon there has been a cytosine-to-thymine transition which changes the corresponding amino acid from a valine to a methionine. To prove that these two basepair substitutions were mutations and not polymorphisms, each mutation was reproduced in vitro and expression plasmids encoding the mutant receptor were transfected into CHO cells lacking a functional LDL receptor. Two permanent cell lines were established: TR-1 163, containing a plasmid coding for an LDL receptor protein with the same mutation as FH-la, and TR-1 178, expressing a plasmid encoding an LDL receptor protein identical to FH-3a. These two cell lines were compared with TR-7 15 cells, a previously described CHO cell line expressing the normal LDL receptor cDNA (21) . The cells were pulse labeled with [35S]-methionine for 1 h before the addition of unlabeled methionine. Cells were collected after varying periods ofchase, solubilized, and subjected to immunoprecipitation using IgG-C7, an MAb directed against the first cysteine-rich binding repeat of the LDL receptor gene (25). The immunoprecipitated proteins were fractionated on a gel and the gel was subjected to fluorography (Fig. 2) . The fluorograms were analyzed by densitometry to assay the relative amounts of LDL receptor protein in the precursor (120 kD) and mature (160 kD) forms. Fig. 2 A shows the analysis of cells transfected with a normal LDL receptor cDNA. After a 30-min chase, > 50% of the LDL receptor protein had matured from the 120-kD precursor to the 160-kD mature form. Fig. 2 B shows the results of a similar analysis of the FH-I-la cells. This cell line made a normally sized 120-kD LDL receptor precursor that was processed to the mature 160-kD form at a much slower rate than seen in the cells transfected with the normal LDL receptor cDNA. It required 2-4 h for 50% of the receptor to reach the GACGCTCA-3') complementary to downstream flanking sequence from intron 9. After amplification the DNA was size-fractionated on a 6% polyacrylamide gel in buffer A, and the 222-bp fragment corresponding to the amplified exon was excised from the gel, purified, and subjected to sequence analysis. Comparison between the normal and FH 3a genes revealed a single base substitution (cytosine to thymidine) causing a single amino acid substitution (valine to methionine) at residue 408. mature 160-kD form. C shows the results of a pulse-chase analysis of the FH-3a cells. These cells also processed the LDL receptor protein slower than the normal cells but more rapidly than the FH-la cells.
It was also noted that the LDL receptor protein synthesized in the FH-3a cells was degraded more rapidly than in the normal or FH-la cells (Fig. 3) CATG). Therefore, it would be predicted that the mutations could be assayed by restriction analysis using these two restriction enzymes. FH-1 a, FH-3a, and FH-6a were analyzed separately for the presence or absence of these two restriction sites (Fig. 4) . Fig . 4 A shows the results of restriction analysis of amplified DNA from subjects FH-6a, FH-la, FH-3a, and the parents of FH-6a. PCR-Dl and end-labeled PCR-D2, 25-base oligonucleotides homologous to sequences flanking the mutation, were used to selectively amplify the 3' region of exon 4 of the LDL receptor gene. The purified 220 bp DNA fragment was subjected to restriction analysis with Dde I and the products were size fractionated on a polyacrylamide gel. In the normal LDL receptor gene, an 87-bp band would be expected due to the presence of an invariant Dde I site in exon 4. In FH-la, a 23-bp band would be expected since a new Dde I site (labeled Dde I-M) is formed. As expected, FHI la (lane 5) is homozygous for the 23-bp band and FH-3a (lane 6) is homozygous for the 87-bp band. FH-6a (lane 4) has both the 87-and 23-bp bands and he shares the abnormal band with his mother (lane 3).
Genomic DNA from these same individuals was subjected to polymerase chain reaction using end-labeled PCR-Nl and PCR-N2, two 25-base oligonucleotides homologous to the intron sequences flanking exon 9, and the resultant 222 bp fragment was subjected to Nla III restriction analysis (Fig. 4 B) . from his father. The other nine Afrikaner FH homozygotes were analyzed in a similar fashion and all the alleles with an LDL receptor haplotype 3 and 15 have the same restriction pattern as FH-la and FH-3a, respectively (data not shown). The nature of the mutation associated with LDL receptor haplotype 16 was not determined but was confirmed not to be either of the two common mutations.
Discussion
In this study we have characterized two common mutations at the LDL receptor locus that make up > 95% of the mutant alleles responsible for FH in a cohort of Afrikaner FH homozygotes living in the Transvaal Province of South Africa. FH has been estimated to have a frequency of at least 1 in 100 in the Afrikaner population, which is five times greater than in the European and North American populations (9, 10) . If this high frequency is due to a founder effect, it would be expected that one or two LDL receptor mutations would predominate in the present population of FH Afrikaners. To estimate the number of different LDL receptor mutations represented in the 12 FH Afrikaner homozygotes available for analysis, we determined their LDL receptor gene haplotypes using 10 RFLPs. At the ,B-globin and phenylalanine hydroxylase loci particular mutations are often in linkage disequilibrium with particular haplotypes (26) (27) (28) . Therefore, we took two subjects homozygous for the two commonly observed haplotypes and sequenced the coding region of their LDL receptor genes and identified two different mutations. Fortuitously, each mutation created a new restriction site enabling indirect detection of the mutation in the remaining FH homozygotes. All the individuals sharing the same haplotypes as FH-la and FH-3a also had the same corresponding mutation, as reflected by restriction enzyme analysis of selectively amplified DNA segments (data not shown). Therefore, each LDL receptor mutation was in linkage disequilibrium with a different RFLP haplotype.
Both mutations resulted in a change in a single amino acid. To exclude the possibility that the amino acid change was an innocent polymorphism, we reproduced and analyzed each mutation in vitro. A The DNAwas remained largely genetically isolated due to their different lantoradiographed guage, culture, and religion. They had large families and were indigested DNA. highly dispersed so that consanguinity was common in the dividuals anaearly generations. The population expanded dramatically in size over a relatively short period of time (35) .
Prior genealogical studies of 29 Afrikaner FH homozygotes studies demonfrom the Transvaal region showed that many of the families ial 120-kD pre-had ancestors who were members of a particular church, the rocessed to the Gereformeerde Kerk (GK) (36) . This church has the smallest e normal recepmembership of the three main Afrikaner church denominareceptor locus tions. Two surnames were found to be common in the Afria similar slow kaner FH pedigrees and these names could be traced back to these mutations original church founders. Of the index families (i.e., the famiLnd binding dolies of the parents of the FH homozygotes), 58% had an affiliaie protein com-tion with the GK and numerous consanguineous marriages 1). Each of these were noted in the early generations of the pedigrees of these 29 ur amino acids Afrikaner FH homozygotes. It would now be of interest to ighly conserved identify which of the two mutations we have identified is arfere with the found in the descendents of this particular religious group.
within this cysNumerous rare genetic disorders have been found to have a demonstrated high frequency in the Afrikaner population including ns from the ER Gaucher's disease, cystic fibrosis, sclerosteosis, variegate pord that proteins phyria, lipoid proteinosis, Huntington's chorea, progressive fally to the Golgi milial heart block, and familial colonic polyposis (1 1, 12) . Pre-1. The mutation sumably, the small founder population represented only a ine-rich ligand small sampling of the European genetic pool and was enriched for particular mutant genes. Most likely, among the original settlers there were one or more individuals (or families) with either one of the two common LDL receptor mutations identified in this study. One may expect that the Afrikaner population will also contain cases of FH caused by mutations at the "background" frequency of 1 in 500; the allele present in FH-2a is presumably one of these. White South Africans have a higher mortality rate from coronary heart disease than any other male population between 25 and 34 y of age (37) and the high frequency of FH in the Afrikaner population may be an important contributing factor. To determine the exact frequency of each mutation in the present Afrikaner population, it would be necessary to screen a large number of FH heterozygotes and homozygotes for the presence of either of the two mutations we identified. This can be easily done using the polymerase chain reaction technique in conjunction with restriction analysis, as we have demonstrated in this paper. If the frequency of these two mutations is high, as we expect, the appropriate molecular assay can be applied to the detection of heterozygotes and the prenatal diagnosis of homozygous FH in the Afrikaner community.
